skip to main content
Refinado por: Nome da Publicação: Clinical Lymphoma, Myeloma And Leukemia remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Material Type:
Artigo
Adicionar ao Meu Espaço

A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Ribrag, Vincent ; Lee, Seung Tae ; Rizzieri, David ; Dyer, Martin J.S. ; Fayad, Luis ; Kurzrock, Razelle ; Andritsos, Leslie ; Bouabdallah, Reda ; Hayat, Amjad ; Bacon, Larry ; Jiang, Yu ; Miah, Kowser ; Delafont, Bruno ; Hamid, Oday ; Anyanwu, Stephanie ; Martinez, Pablo ; Hess, Brian

Clinical lymphoma, myeloma and leukemia, 2021-05, Vol.21 (5), p.309-317.e3 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

2
AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies
Material Type:
Artigo
Adicionar ao Meu Espaço

AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies

Pammaraju, Naveen ; Kantarjian, Hagop ; Sweet, Kendra ; Wang, Eunice S. ; Lane, Andrew A. ; Ali, Haris ; Stein, Anthony S. ; Yacoub, Abdulraheem ; Rizzieri, David ; Vasu, Sumithira ; Gupta, Vikas ; Lee, Sangmin ; Schiller, Gary J. ; Foran, James M. ; Taparia, Minakshi S. ; Rosenblat, Todd L. ; Walter, Roland B. ; Sieminski, Deborah ; Anant, Madhu ; Patnaik, Mrinal M. ; Mughal, Tariq I. ; Konopleva, Marina

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S246-S247 [Periódico revisado por pares]

Texto completo disponível

3
Poster: AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies
Material Type:
Artigo
Adicionar ao Meu Espaço

Poster: AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies

Pammaraju, Naveen ; Kantarjian, Hagop ; Sweet, Kendra ; Wang, Eunice S. ; Lane, Andrew A. ; Ali, Haris ; Stein, Anthony S. ; Yacoub, Abdulraheem ; Rizzieri, David ; Vasu, Sumithira ; Gupta, Vikas ; Lee, Sangmin ; Schiller, Gary J. ; Foran, James M. ; Taparia, Minakshi S. ; Rosenblat, Todd L. ; Walter, Roland B. ; Sieminski, Deborah ; Anant, Madhu ; Patnaik, Mrinal M. ; Mughal, Tariq I. ; Konopleva, Marina

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S126 [Periódico revisado por pares]

Texto completo disponível

4
Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Heyman, Benjamin ; Rizzieri, David ; Adams, David J. ; De Castro, Carlos ; Diehl, Louis ; Li, Zhiguo ; Moore, Joseph ; Beaven, Anne

Clinical lymphoma, myeloma and leukemia, 2018-10, Vol.18 (10), p.679-686 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

5
AML-373: Tagraxofusp, a CD123-Targeted Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Landmark Clinical Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

AML-373: Tagraxofusp, a CD123-Targeted Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Landmark Clinical Trial

Pemmaraju, Naveen ; Lane, Andrew ; Sweet, Kendra ; Stein, Anthony ; Vasu, Sumithira ; Blum, William ; Rizzieri, David ; Wang, Eunice ; Duvic, Madeleine ; Brooks, Christopher ; Sloan, J. Mark ; Rosenblat, Todd ; Akilov, Oleg ; Mughal, Tariq ; Lancet, Jeffrey ; Kantarjian, Hagop ; Konopleva, Marina

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S209-S210 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

6
A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse
Material Type:
Artigo
Adicionar ao Meu Espaço

A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse

Advani, Anjali S ; Shadman, Mazyar ; Ali-Osman, Francis ; Barker, Andrew ; Rybicki, Lisa ; Kalaycio, Matt ; Sekeres, Mikkael A ; de Castro, Carlos M ; Diehl, Louis F ; Moore, Joseph O ; Beaven, Anne ; Copelan, Ed ; Sobecks, Ronald ; Talea, Parisa ; Rizzieri, David A

Clinical lymphoma, myeloma and leukemia, 2010-12, Vol.10 (6), p.473-476 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

7
Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update
Material Type:
Artigo
Adicionar ao Meu Espaço

Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update

Mauro, Michael J., MD ; Dakhil, Shaker, MD ; Cortes, Jorge E., MD ; Rizzieri, David A., MD ; Bonifacio, Gaetano, MD ; Dautaj, Ilva ; Warsi, Ghulam ; Heinrich, Michael C., MD ; Goldberg, Stuart L., MD ; Catchatourian, Rosalind, MD ; Kuriakose, Philip, MD ; Radich, Jerald, MD

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.S37-S37 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

8
Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia

Rizzieri, David ; LoRusso, Samantha ; Tse, William ; Khan, Khuda ; Advani, Anjali ; Moore, Joseph ; Karsten, Verena ; Cahill, Ann ; Gerson, Stanton L

Clinical lymphoma, myeloma and leukemia, 2010-06, Vol.10 (3), p.211-216 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.